Vectura Group PLC said it it has signed a European collaboration, development and licence agreement with a leading international pharmaceutical company for its combination asthma therapy VR315.
Vectura Group PLC said it it has signed a European collaboration, development and licence agreement with a leading international pharmaceutical company for its combination asthma therapy VR315.